Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Presentation TCT 2023

TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

Presenter: Imran Shah

October 25, 2023

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

Presentation EuroPCR 2022

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Presenter: Giuseppe Tarantini

May 31, 2022

Presentation JIM 2019

Small vessel intervention: Leading the way with Resolute Onyx

Presenter: Saidur Rahman Khan

February 15, 2019

Presentation JIM 2018

Complexity made simple: Resolute Onyx the advanced workhorse

Presenter: Fausto Castriota

February 23, 2018

Presentation TCT 2017

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price

October 30, 2017

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Roxana Mehran

October 30, 2016

Presentation TCT 2015

Durable-Polymer DES 5-Year Outcomes: RESOLUTE Update

Presenter: Stephen G. Ellis, John A. Ormiston, Sigmund Silber

October 11, 2015

Presentation EuroPCR 2015

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Presenter: Sigmund Silber

May 19, 2015

Presentation

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Presenter: M.K. Lam

October 31, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Very Small Vessels in the RESOLUTE Global Clinical Program

Presenter: Antonio Serra

September 16, 2014

Presentation TCT 2014

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Presenter: Ganesh Manoharan

September 16, 2014

Presentation TCT 2014

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Presenter: Carlo Di Mario

September 16, 2014

Presentation TCT 2014

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Presenter: Clemens von Birgelen

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

Presentation CIT 2014

RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting Stent

Presenter: Dr. Chen Shaoliang

March 22, 2014

Presentation

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Presenter: 115704|Sigmund Silber

February 17, 2014

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

Presentation TCT 2013

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Presenter: Samer Arnous

October 29, 2013

Advertisement

TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Small vessel intervention: Leading the way with Resolute Onyx

Complexity made simple: Resolute Onyx the advanced workhorse

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Stent Design and Comprehensive Data Review: Resolute Cobalt Chromium Durable Polymer-Based Zotarolimus-Eluting Stents

Durable-Polymer DES 5-Year Outcomes: RESOLUTE Update

Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Percutaneous Coronary Intervention of Very Small Vessels in the RESOLUTE Global Clinical Program

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting Stent

Lack of Association Between DAPT Use and Stent Thrombosis Between 1 and 12 Months Following Resolute ZES Implantation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content